Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Oct 27, 2022; 14(10): 1120-1130
Published online Oct 27, 2022. doi: 10.4240/wjgs.v14.i10.1120
Table 3 Long-term efficacy evaluation after cap-assisted endoscopic sclerotherapy treatment (follow-up in 2021, n = 149), n (%)
Efficacy
Excellent
Good
Poor
χ2
P value
Stage Ⅰ46 (68.6)18 (26.9)3 (4.5)
Stage Ⅱ22 (57.9)13(34.2)3 (7.9)4.780.572
Stage Ⅲ20 (54.1)16 (43.2)1 (2.7)
Stage Ⅳ4 (57.1)3 (42.9)0 (0)